Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-20

Clinical Trial Update: Hypofractionated Online Adaptive Radiotherapy of Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update summarizes a Phase 2 study evaluating hypofractionated online adaptive radiotherapy for breast cancer, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING